Free Trial
ASX:OVN

Oventus Medical (OVN) Stock Price, News & Analysis

Oventus Medical logo

About Oventus Medical Stock (ASX:OVN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
289,932 shs
Average Volume
N/A
Market Capitalization
A$4.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Oventus Medical Limited, a medical device company, engages in the development and commercialization of oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

Receive OVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oventus Medical and its competitors with MarketBeat's FREE daily newsletter.

OVN Stock News Headlines

How to Get Help Paying Medical Bills
Travel Medical Insurance Plans for Emergency Coverage
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Oventus Medical Ltd (OVN)
See More Headlines

OVN Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Oventus Medical investors own include United Royale (URYL), MariMed (MRMD), ATI (ATI) and Alpha Lithium (APHLF).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:OVN
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$10.29 million
Net Margins
-916.66%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$1.09 million
Price / Cash Flow
5.11
Book Value
A$0.08 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$4.83 million
Optionable
Not Optionable
Beta
0.66
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (ASX:OVN) was last updated on 6/27/2025 by MarketBeat.com Staff
From Our Partners